Preprint Review Version 2 Preserved in Portico This version is not peer-reviewed

Angiogenesis in Lung Cancer: Understanding the Roles of Growth Factors

Version 1 : Received: 23 August 2023 / Approved: 24 August 2023 / Online: 25 August 2023 (11:07:02 CEST)
Version 2 : Received: 25 August 2023 / Approved: 28 August 2023 / Online: 29 August 2023 (09:24:16 CEST)

A peer-reviewed article of this Preprint also exists.

Ngaha, T.Y.S.; Zhilenkova, A.V.; Essogmo, F.E.; Uchendu, I.K.; Abah, M.O.; Fossa, L.T.; Sangadzhieva, Z.D.; D. Sanikovich, V.; S. Rusanov, A.; N. Pirogova, Y.; Boroda, A.; Rozhkov, A.; Kemfang Ngowa, J.D.; N. Bagmet, L.; I. Sekacheva, M. Angiogenesis in Lung Cancer: Understanding the Roles of Growth Factors. Cancers 2023, 15, 4648. Ngaha, T.Y.S.; Zhilenkova, A.V.; Essogmo, F.E.; Uchendu, I.K.; Abah, M.O.; Fossa, L.T.; Sangadzhieva, Z.D.; D. Sanikovich, V.; S. Rusanov, A.; N. Pirogova, Y.; Boroda, A.; Rozhkov, A.; Kemfang Ngowa, J.D.; N. Bagmet, L.; I. Sekacheva, M. Angiogenesis in Lung Cancer: Understanding the Roles of Growth Factors. Cancers 2023, 15, 4648.

Abstract

Research has shown the role of growth factors in lung cancer angiogenesis. Angiogenesis promotes lung cancer progression by stimulating tumor growth, enhancing tumor invasion, contributing to metastasis, and modifying immune system responses within the tumor microenvironment. As a result, new treatment techniques based on the anti-angiogenic characteristics of compounds have been developed. These compounds selectively block the growth factors themselves, their receptors, or the downstream signaling pathways activated by these growth factors. The EGF and VEGF families are the primary targets in this approach, and several studies are being conducted to propose anti-angiogenic drugs that are increasingly suitable for the treatment of lung cancer, either as monotherapy or as combined therapy. The efficacy results are encouraging, but a caution must be placed on the higher risk of toxicity, outlining the importance of personalized follow-up in the management of these patients.

Keywords

Angiogenesis; Growth factors; Lung cancer; Tumor microenvironment; Anti-angiogenic therapy

Subject

Medicine and Pharmacology, Oncology and Oncogenics

Comments (1)

Comment 1
Received: 29 August 2023
Commenter: Yvan Sinclair NGAHA TCHAWE
Commenter's Conflict of Interests: Author
Comment: references and copyrighting
+ Respond to this comment

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 1
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.